Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

Mise à jour : Il y a 4 ans
Référence : NCT00663169

Femme et Homme

Extrait

This is an exploratory proof-of-concept study to evaluate the safety and efficacy of canakinumab (ACZ885) for inflammation and pain associated with acute gouty arthritis.


Critère d'inclusion

  • Arthritis, Gouty

Liens